title: Does raloxifene reduce risk of vertebral fractures? Is this another, brighter way to treat osteoporosis?
authors.affiliation: Department of Family and Community Medicine, University of Toronto, Ontario.
authors.forename: S
authors.initials: S
authors.lastname: Hathirat
authors.forename: M F
authors.initials: MF
authors.lastname: Evans
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005194:Family Practice; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D018579:Patient Selection; D020849:Raloxifene Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D016103:Spinal Fractures / Q000517:prevention & control*
chemical_list: D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride